CJC-1295 without DAC 2 mg

CJC-1295 without DAC is a synthetic modified peptide compound designed for laboratory research. This molecular variant lacks the Drug Affinity Complex (DAC) modification, resulting in different stability characteristics in experimental conditions.

The compound features a precisely engineered 29-amino acid sequence structure, showing selective receptor binding properties in vitro studies. Without the DAC modification, this variant demonstrates different pharmacokinetic properties in solution compared to its DAC-modified counterpart, making it particularly suitable for specific types of acute laboratory studies and molecular signaling research.